Literature DB >> 15321704

Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives.

Denis M Tebit1, Léopold Zekeng, Lazare Kaptué, Lutz Gürtler, Oliver T Fackler, Oliver T Keppler, Ottmar Herchenröder, Hans-Georg Kräusslich.   

Abstract

In this report, we describe the construction and characterization of the first full-length infectious molecular clone from the Cameroonian HIV-1 group O primary isolate MVP8913. Virus obtained after transfection of the proviral clone pCMO2.3 replicated to levels comparable to its parental isolate in the human T-cell line PM-1, although replication was reduced by fivefold in peripheral blood mononuclear cells (PBMC) and was barely detectable in primary monocyte-derived macrophages (MDM). Phylogenetic analysis of the complete proviral sequence revealed a closer relationship to ANT70 than to MVP5180, the two prototypic group O primary isolates. All reading frames for structural and accessory genes were open except for vpr that contained an in-frame stop codon. In the nef gene, a mutation disrupting the functionally important myristoylation signal was observed. Repairing the defect in nef enhanced replication in PBMC and MDM, although repairing the vpr defect only affected replication in MDM, consistent with the known phenotypes of vpr and nef mutants in HIV-1 group M viruses. Repairing both vpr and nef showed an additive effect, but the resulting virus was still impaired compared to the parental isolate. This defect was overcome when the gag-pol coding region was exchanged for that from another O-type isolate giving rise to the proviral clone pCMO2.5. Virus obtained from pCMO2.5 replicated with similar kinetics as the parental O-type isolate in both PBMC and MDM, making this proviral clone a valuable tool for further studies on functional characteristics of HIV-1 group O viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321704     DOI: 10.1016/j.virol.2004.05.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Authors:  Denis M Tebit; Hamish Patel; Annette Ratcliff; Elodie Alessandri; Joseph Liu; Crystal Carpenter; Jean-Christophe Plantier; Eric J Arts
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-16       Impact factor: 2.205

2.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

3.  Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.

Authors:  Silvia F Kluge; Katharina Mack; Shilpa S Iyer; François M Pujol; Anke Heigele; Gerald H Learn; Shariq M Usmani; Daniel Sauter; Simone Joas; Dominik Hotter; Frederic Bibollet-Ruche; Lindsey J Plenderleith; Martine Peeters; Matthias Geyer; Paul M Sharp; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

4.  Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assay.

Authors:  Olga A Nikolaitchik; Andrea Galli; Michael D Moore; Vinay K Pathak; Wei-Shau Hu
Journal:  J Mol Biol       Date:  2011-02-03       Impact factor: 5.469

5.  Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors.

Authors:  Denis M Tebit; Michael Lobritz; Matthew Lalonde; Taina Immonen; Kamlendra Singh; Stefanos Sarafianos; Ottmar Herchenröder; Hans-Georg Kräusslich; Eric J Arts
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

6.  The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Hiroaki Takeuchi; Yasuhiro Ikeda
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

7.  Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.

Authors:  Silvia Geuenich; Lars Kaderali; Ina Allespach; Serkan Sertel; Oliver T Keppler
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

8.  Host and viral determinants of Mx2 antiretroviral activity.

Authors:  Idoia Busnadiego; Melissa Kane; Suzannah J Rihn; Hannah F Preugschas; Joseph Hughes; Daniel Blanco-Melo; Victoria P Strouvelle; Trinity M Zang; Brian J Willett; Chris Boutell; Paul D Bieniasz; Sam J Wilson
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  Lack of adaptation to human tetherin in HIV-1 group O and P.

Authors:  Su Jung Yang; Lisa A Lopez; Colin M Exline; Kevin G Haworth; Paula M Cannon
Journal:  Retrovirology       Date:  2011-09-28       Impact factor: 4.602

10.  Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC.

Authors:  Qiwei Zhang; Xiaomin Zhang; Hao Wu; Donald Seto; Hao-Jie Zhang; Zhiwei Chen; Chengsong Wan; Bo-Jian Zheng
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.